#Herd Immunity

Public Healthsambadenglish.com

Sero-survey: 3 Odisha districts achieve herd immunity against COVID-19

Bhubaneswar: As per findings of the fourth round of sero-survey, over 70 per cent of the population in Odisha’s Ganjam district has developed anti-bodies against COVID-19. The survey conducted between June 16 and 20 revealed that Ganjam district has highest sero-prevalence of 70.9 %, which means around 71 % people in the district were infected with the virus and have recovered. Rayagada and Koraput districts have 63 % and 61.3 % sero-prevelance.

Mass vaccination of children to be considered for Covid herd immunity

The prospect of a mass vaccination programme for children in Ireland has been raised, after a HSE official suggested nine out of 10 people will need to be vaccinated to reach herd immunity against Covid-19. Dr Colm Henry, the HSE’s chief clinical officer, said the National Immunisation Advisory Committee (Niac)...

Irish immunology expert: Herd immunity could be impossible

A professor of immunology from Maynooth University has predicted some variants will continue to cause infections in those who have been vaccinated. Professor Paul Moynagh has told Newstalk that herd immunity “could be very difficult to achieve” due to the emergence of new variants of Covid-19 and the percentage of unvaccinated people, including children.
New York City, NYFOXBusiness

‘Herd Immunity’ at Wall Street firms keeps return to office on track

Despite an uptick in COVID-19 cases, Wall Street chieftains are confident they have "herd immunity" among their New York City employees. CEOs of Morgan Stanley, JPMorgan and Goldman Sachs, at this time, say rank and file employees, of which an estimated 90% are vaccinated, will be able to continue returning to the office, FOX Business has learned.

Herd immunity 'could be very difficult to achieve' - Paul Moynagh

It's going to very difficult to achieve herd immunity, according to immunology professor Paul Moynagh. It comes as the European Medicines Agency (EMA) is meeting to discuss extending the use of the Spikevax - previously called Moderna - vaccine to include children aged 12 to 18. This would add to...